DEC1 is a downstream target of TGF-β with sequence-specific transcriptional repressor activities

Leigh Zawel, Jian Yu, Christopher J. Torrance, Sanford Markowitz, Kenneth W. Kinzler, Bert Vogelstein, Shibin Zhou

Research output: Contribution to journalArticlepeer-review


To identify genes that mediate transforming growth factor-β (TGF-β) signaling, a colorectal cancer cell line that was sensitive to the growth inhibitory effects of this cytokine was created. We then determined the global gene expression profiles of these cells, and those of HaCaT human keratinocytes, in the presence and absence of TGF-β. Of the several genes identified in this screen, DEC1 was of particular note in light of the rapidity and consistency of its induction and its potential biochemical activities. We identified a consensus DNA-binding site for DEC1 and showed that DEC1 could repress the transcription of a reporter containing this binding site in its promoter. Finally, both alleles of the DEC1 locus in HaCaT cells were inactivated through targeted homologous recombination. This approach revealed that DEC1 induction was not required for the growth inhibition mediated by TGF-β in this line. However, DEC1 may function in concert with other signaling components to mediate certain biologic effects of TGF-β.

Original languageEnglish (US)
Pages (from-to)2848-2853
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number5
StatePublished - Mar 5 2002

ASJC Scopus subject areas

  • General


Dive into the research topics of 'DEC1 is a downstream target of TGF-β with sequence-specific transcriptional repressor activities'. Together they form a unique fingerprint.

Cite this